Clinical Research on Orphan Drugs
The Orphan Drug clinical exploration program provides orphan status to medicines and biologics which are defined as those intended for the treatment, forestalment or opinion of a rare complaint or situation, which is one that disturb lower than persons. We can see momentous progress in the development of treatments for rare conditions, also known as orphan medicines. Especially the agency authorized 32 new medicines and biologics with title named as orphan medicines
Related Conference of Clinical Research on Orphan Drugs
August 21-22, 2024
5th International conference on Vaccines, Vaccination and Immunization
Paris, France
September 12-13, 2024
19th International Conference on Allergy and Clinical Immunology
Paris, France
October 24-25, 2024
5th International Conference on Immunology And Immunotherapy
Zurich, Switzerland
Clinical Research on Orphan Drugs Conference Speakers
Recommended Sessions
- Orphan medicinal products
- Advance therapies for rare diseases
- Clinical Research on Orphan Drugs
- Immunological Rare Diseases
- Infectious Diseases
- Orphan Diseases and public health
- Orphan Drugs
- Orphan Drugs and Potentiality
- Orphan drugs ethical issues
- Rare Autoimmune Diseases
- Rare Genetic Disorder
- Rare Gynaecological and Obstetrical Diseases
- Rare Mental and Behavioural Disorders
- Rare Obesity and Metabolic Disorders
- Rare Oncology
- Rare Skin Diseases
Related Journals
Are you interested in
- Advances in Molecular Immunology - ALLERGY 2024 (France)
- Allergen Identification and Characterization - ALLERGY 2024 (France)
- Biomarkers for Allergy Diagnosis and Treatment - ALLERGY 2024 (France)
- Case Studies in Allergy Diagnosis and Management - ALLERGY 2024 (France)
- Clinical Trials and Translational Research in Allergy and Immunology - ALLERGY 2024 (France)
- Digital Health and Telemedicine in Allergy Care - ALLERGY 2024 (France)
- Epidemiology and Population Studies in Allergic Diseases - ALLERGY 2024 (France)
- Immune Responses to Vaccination - ALLERGY 2024 (France)
- Immunogenetics and Allergic Susceptibility - ALLERGY 2024 (France)
- Immunological Aspects of Drug Allergies - ALLERGY 2024 (France)
- Immunological Basis of Food Allergy - ALLERGY 2024 (France)
- Immunological Mechanisms in Autoimmune Diseases - ALLERGY 2024 (France)
- Immunomodulation in Allergy Management - ALLERGY 2024 (France)
- Immunopathogenesis of Allergic Diseases - ALLERGY 2024 (France)
- Immunotherapy for Allergic Conditions - ALLERGY 2024 (France)
- Inflammatory Pathways in Asthma and Allergic Rhinitis - ALLERGY 2024 (France)
- Mechanisms of Immunodeficiency Diseases - ALLERGY 2024 (France)
- Novel Therapeutic Approaches for Allergic Disorders - ALLERGY 2024 (France)
- Role of Microbiota in Allergic Disorders - ALLERGY 2024 (France)